Total Payments
$7,659
2024 Payments
$693.26
Companies
44
Transactions
281
Medicare Patients
20,628
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$5,620 (73.4%)
Travel$1,962 (25.6%)
Education$75.95 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,620 | 274 | 73.4% |
| Travel and Lodging | $1,962 | 1 | 25.6% |
| Education | $75.95 | 6 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AngioDynamics, Inc. | $2,399 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $637.14 | 41 | $0 (2024) |
| Amgen Inc. | $550.11 | 33 | $0 (2024) |
| PFIZER INC. | $476.17 | 33 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $447.46 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $376.15 | 9 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $367.01 | 24 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $350.54 | 20 | $0 (2024) |
| Medtronic Vascular, Inc. | $271.53 | 5 | $0 (2020) |
| Merck Sharp & Dohme LLC | $248.65 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $693.26 | 38 | PFIZER INC. ($172.09) |
| 2023 | $679.15 | 36 | PFIZER INC. ($124.50) |
| 2022 | $846.87 | 45 | AstraZeneca Pharmaceuticals LP ($130.62) |
| 2021 | $700.27 | 41 | AstraZeneca Pharmaceuticals LP ($159.01) |
| 2020 | $188.86 | 8 | Boston Scientific Corporation ($89.64) |
| 2019 | $893.23 | 44 | Boehringer Ingelheim Pharmaceuticals, Inc. ($142.50) |
| 2018 | $3,337 | 54 | AngioDynamics, Inc. ($2,347) |
| 2017 | $319.77 | 15 | Aralez Pharmaceuticals US Inc. ($81.33) |
All Payment Transactions
281 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: VACCINES | ||||||
| 11/26/2024 | PFIZER INC. | VYNDAMAX (Drug) | Education | In-kind items and services | $19.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/12/2024 | PFIZER INC. | VYNDAMAX (Drug) | Education | In-kind items and services | $19.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.44 | General |
| Category: Cardiovascular | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: VACCINES | ||||||
| 10/01/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/01/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $1.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/09/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/08/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.68 | General |
| Category: Cardiovascular | ||||||
| 08/07/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: VACCINES | ||||||
| 08/01/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $23.63 | General |
| Category: Coronary | ||||||
| 07/17/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.03 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/01/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/20/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/13/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/28/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/23/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 5,395 | 7,314 | $1.6M | $549,432 |
| 2022 | 47 | 5,211 | 6,993 | $1.4M | $537,452 |
| 2021 | 46 | 5,650 | 7,416 | $1.6M | $574,750 |
| 2020 | 45 | 4,372 | 5,549 | $1.1M | $440,898 |
Total Patients
20,628
Total Services
27,272
Medicare Billing
$2.1M
Procedure Codes
189
All Medicare Procedures & Services
189 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 781 | 1,084 | $301,352 | $144,841 | 48.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 240 | 240 | $230,640 | $84,365 | 36.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 382 | 388 | $159,345 | $51,761 | 32.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 341 | 341 | $138,446 | $48,817 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 332 | 377 | $74,269 | $34,760 | 46.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 129 | 507 | $38,025 | $21,645 | 56.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 121 | 131 | $53,231 | $18,336 | 34.4% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 245 | 250 | $119,316 | $17,188 | 14.4% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 22 | 22 | $41,008 | $15,097 | 36.8% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 112 | 112 | $43,008 | $13,600 | 31.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 225 | 227 | $83,282 | $11,862 | 14.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 245 | 246 | $37,638 | $11,499 | 30.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 831 | 1,097 | $37,298 | $11,393 | 30.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 72 | 88 | $18,385 | $8,452 | 46.0% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 40 | 40 | $20,880 | $8,243 | 39.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 66 | 66 | $16,962 | $7,817 | 46.1% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 76 | 78 | $14,508 | $3,912 | 27.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 65 | 65 | $29,262 | $3,754 | 12.8% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 39 | 414 | $9,936 | $3,327 | 33.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 39 | 54 | $9,234 | $3,312 | 35.9% |
| 76706 | Ultrasound scan of abdominal aorta | Office | 2023 | 26 | 26 | $7,124 | $2,853 | 40.1% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 14 | 14 | $7,196 | $2,679 | 37.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 38 | $5,472 | $2,426 | 44.3% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 18 | 80 | $2,800 | $2,022 | 72.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 273 | 314 | $9,053 | $1,932 | 21.3% |
About Dr. Ajith Kumar, M.D
Dr. Ajith Kumar, M.D is a Interventional Cardiology healthcare provider based in Newark, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386611267.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ajith Kumar, M.D has received a total of $7,659 in payments from pharmaceutical and medical device companies, with $693.26 received in 2024. These payments were reported across 281 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($5,620).
As a Medicare-enrolled provider, Kumar has provided services to 20,628 Medicare beneficiaries, totaling 27,272 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 189 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Newark, DE
- Active Since 03/01/2006
- Last Updated 12/22/2025
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1386611267
Products in Payments
- BRILINTA (Drug) $609.36
- XARELTO (Drug) $367.01
- ELIQUIS (Drug) $355.86
- LifeVest (Device) $350.54
- Repatha (Biological) $337.62
- ENTRESTO (Drug) $289.47
- PRADAXA (Drug) $254.27
- VERQUVO (Drug) $248.65
- Corlanor (Drug) $212.49
- LEQVIO (Drug) $157.99
- VYNDAQEL (Drug) $156.11
- Resolute (Device) $147.41
- JARDIANCE (Drug) $121.88
- Micra (Device) $120.00
- cobas 8000 Core Unit (Device) $117.97
- ZONTIVITY (Drug) $114.83
- GENERAL - STENTS (Device) $89.64
- PRALUENT (Drug) $72.51
- NEXLETOL (Drug) $66.97
- PRALUENT ALIROCUMAB INJECTION (Biological) $60.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Newark
Dr. Ashish Parikh, Md, Facc, MD, FACC
Interventional Cardiology — Payments: $52,722
Interventional Cardiology $52,722
Kirk Garratt, Md, MD
Interventional Cardiology — Payments: $35,346
Interventional Cardiology $35,346
Abhishek Sharma, Md, MD
Interventional Cardiology — Payments: $27,129
Interventional Cardiology $27,129
Trevor Atherley, Md, MD
Interventional Cardiology — Payments: $10,014
Interventional Cardiology $10,014
Dr. Kalpeshkumar Shah, Md, MD
Interventional Cardiology — Payments: $8,321
Interventional Cardiology $8,321
James Hopkins, M.d, M.D
Interventional Cardiology — Payments: $7,765
Interventional Cardiology $7,765